Laia Escude - Publications

Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.

Journal: Journal of hepatology

Published: September 14, 2023

Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.

Journal: Hepatology (Baltimore, Md.)

Published: May 05, 2022

Non-invasive tests for clinically significant portal hypertension after HCV cure.

Journal: Journal of hepatology

Published: January 25, 2022

Results of a multidisciplinary strategy to improve the management of cardiovascular risk factors after liver transplantation.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: January 10, 2022

Primary herpes simplex virus type 1 infection with acute liver failure in solid organ transplantation: Report of three cases and review.

Journal: IDCases

Published: November 12, 2021

The Role of Arterial Stiffness in the Estimation of Cardiovascular Risk in Liver Transplant Recipients.

Journal: Transplantation direct

Published: September 26, 2021

Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.

Journal: Journal of hepatology

Published: May 27, 2021

The challenge of diagnosing Wilson's disease in patients with MAFLD.

Journal: Gastroenterologia y hepatologia

Published: May 19, 2021

Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: October 13, 2013